Revenue: The sum of all revenue fields included for a company's operating activities.
ARS Pharmaceuticals, Inc. (SPRY) had Revenue of $7.97M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$7.97M |
$-33.94M |
|
$1.09M |
|
$6.88M |
|
$45.15M |
|
$-37.18M |
|
$3.24M |
|
$-33.94M |
|
$-33.94M |
|
$-33.94M |
|
$-33.94M |
|
$-33.94M |
|
$-33.94M |
|
$-37.18M |
|
$-38.86M |
|
98.06M |
|
98.06M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$303.86M |
|
$1.07M |
|
$23.46M |
|
$327.32M |
|
$27.62M |
|
$69.38M |
|
$70.72M |
|
$98.34M |
|
$228.97M |
|
$221.73M |
|
$228.97M |
|
98.13M |
|
| Cash Flow Statement Financials | |
$-40.74M |
|
$29.06M |
|
$0.72M |
|
$50.82M |
|
$39.86M |
|
$-10.95M |
|
$5.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.00 |
|
-- |
|
-- |
|
0.23 |
|
0.30 |
|
86.28% |
|
-466.29% |
|
-466.29% |
|
-- |
|
-425.69% |
|
-425.69% |
|
$-40.83M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.15 |
|
0.86 |
|
105.01 |
|
-14.82% |
|
-15.31% |
|
-10.37% |
|
-11.38% |
|
$2.33 |
|
$-0.42 |
|
$-0.42 |
|